VAUGHAN, ON, Aug. 8, 2018 /CNW/ – CannTrust Holdings Inc., one of Canada’sleading licensed producers and most trusted brands of cannabis announced today that the Company is accelerating its exclusive partnership with Apotex Inc., the largest Canadian-owned generic pharmaceutical company and a global leader and innovator in the production and distribution of high-quality, affordable medicines. Ahead of schedule, the partnership is developing alternate dosage formats for medical cannabis products, which will advance CannTrust’s leadership in the medical cannabis market in Canada, and on a global basis.
Full Article: newswire.ca